[Luteal insufficiency and benign breast diseases. Study in the light of data from the combined LH-RH + TRH test together with the study of ovarian steroids].
Luteal deficiency has been attributed a patho-physiologic role in benign fibro-cystic breast disease, whereas Prolactin would not be involved in this disease. To tes these hypotheses, patients with fibro-cystic breast disease have been investigated through the combined LH-RH + TRH test, coupled with ovarian steroids estimations. 63 menstruating patients with ovulatory cycles, as evidenced by the temperature curve and proven fibro-cystic breast disease, as demonstrated by senography and thermogrphy and/or operation, have been selected for this study. The findings do not favour the role of luteal dificiency but rather the role of PRL hyperactivity in the pathol-physiology of fibro-cySTIC BREAST DISEASE.
D001941:Breast Diseases / Q000209:etiology* / Q000503:physiopathology; D004967:Estrogens / Q000097:blood*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood*; D007987:Gonadotropin-Releasing Hormone; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood*; D008599:Menstruation Disturbances / Q000150:complications*; D011374:Progesterone / Q000097:blood*; D011863:Radioimmunoassay; D013739:Testosterone / Q000097:blood*; D013973:Thyrotropin-Releasing Hormone
D004967:Estrogens; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D011374:Progesterone; D013973:Thyrotropin-Releasing Hormone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone
Insuffisance lutéale et mastopathies bénignes. Etude à la lumière des données de l'épreuve combinée LH-RH + TRH couplée à l'étude des stéroïdes ovariens.